| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-3223(01)01270-7 |
| P698 | PubMed publication ID | 11750894 |
| P2093 | author name string | Stoll C | |
| Roozendaal B | |||
| Schelling G | |||
| Briegel J | |||
| Kapfhammer HP | |||
| Rothenhäusler HB | |||
| P2860 | cites work | A comparison of the adrenocortical response during septic shock and after complete recovery | Q71752741 |
| Life and near-death in the intensive care unit. A personal experience | Q71987544 | ||
| Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims | Q73179176 | ||
| The acute stress response following motor vehicle accidents and its relation to PTSD | Q73546411 | ||
| Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties | Q73583117 | ||
| Urinary catecholamines and cortisol in recent-onset posttraumatic stress disorder after motor vehicle accidents | Q73875750 | ||
| Health-related quality of life and post-traumatic stress disorder in patients after cardiac surgery and intensive care treatment | Q74234372 | ||
| Sensitivity and specificity of a screening test to document traumatic experiences and to diagnose post-traumatic stress disorder in ARDS patients after intensive care treatment | Q78200699 | ||
| Involvement of the amygdala in memory storage: Interaction with other brain systems | Q29303497 | ||
| APACHE II: a severity of disease classification system | Q29547729 | ||
| Memory--a century of consolidation | Q29618665 | ||
| Enhanced memory for emotional material following stress-level cortisol treatment in humans. | Q31883931 | ||
| Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala | Q33744022 | ||
| Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study | Q33861751 | ||
| Acute cortisone administration impairs retrieval of long-term declarative memory in humans | Q33895199 | ||
| Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care | Q33948245 | ||
| Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. | Q34168752 | ||
| Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder | Q34177792 | ||
| Reversal of late septic shock with supraphysiologic doses of hydrocortisone | Q34465500 | ||
| Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder | Q36449700 | ||
| Adrenocortical suppression blocks the memory-enhancing effects of amphetamine and epinephrine | Q37716438 | ||
| Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. | Q41118221 | ||
| Stress and glucocorticoids impair retrieval of long-term spatial memory | Q46850061 | ||
| Survival, morbidity, and quality of life after discharge from intensive care | Q48716859 | ||
| Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD | Q48809887 | ||
| Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. | Q48963309 | ||
| A prospective study of heart rate response following trauma and the subsequent development of posttraumatic stress disorder. | Q50881564 | ||
| Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. | Q50893723 | ||
| Once bitten, twice shy: beyond the conditioning model of PTSD. | Q51144104 | ||
| The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. | Q51978484 | ||
| Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. | Q53775784 | ||
| The ACCP-SCCM consensus conference on sepsis and organ failure. | Q55041019 | ||
| Effect of previous trauma on acute plasma cortisol level following rape. | Q55063220 | ||
| Urinary Free-Cortisol Levels in Posttraumatic Stress Disorder Patients | Q57311804 | ||
| Abuse-Related Posttraumatic Stress Disorder | Q58841223 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| septic shock | Q1765564 | ||
| hydrocortisone | Q26981430 | ||
| P304 | page(s) | 978-985 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors | |
| P478 | volume | 50 |
| Q22306248 | A Critical Analysis of Approaches to Targeted PTSD Prevention: Current Status and Theoretically Derived Future Directions |
| Q30238710 | A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae |
| Q36897335 | A final common pathway for depression: implications for therapy |
| Q30491982 | A final common pathway for depression? Progress toward a general conceptual framework |
| Q34645523 | A genotype-specific, randomized controlled behavioral intervention to improve the neuroemotional outcome of cardiac surgery: study protocol for a randomized controlled trial |
| Q37397062 | A pilot investigation of the association of genetic polymorphisms regulating corticotrophin-releasing hormone with posttraumatic stress and depressive symptoms in medical-surgical intensive care unit survivors |
| Q38911944 | An Evidence-Based Review of Early Intervention and Prevention of Posttraumatic Stress Disorder |
| Q34502687 | Awake/sleep cortisol levels and the development of posttraumatic stress disorder in injury patients with peritraumatic dissociation |
| Q93165277 | Biofeedback-Assisted Resilience Training for Traumatic and Operational Stress: Preliminary Analysis of a Self-Delivered Digital Health Methodology |
| Q36108369 | Bouncing back - trauma and the HPA-axis in healthy adults |
| Q60305820 | Characterizing changes in glucocorticoid receptor internalization in the fear circuit in an animal model of post traumatic stress disorder |
| Q34610802 | Clearance of fear memory from the hippocampus through neurogenesis by omega-3 fatty acids: a novel preventive strategy for posttraumatic stress disorder? |
| Q45246932 | Conceptually driven pharmacologic approaches to acute trauma. |
| Q38883016 | Coping as a Multifaceted Construct: Associations With Psychological Outcomes Among Family Members of Mechanical Ventilation Survivors |
| Q97094957 | Corticosterone after acute stress prevents the delayed effects on the amygdala |
| Q46648683 | Corticosterone combined with intramedial prefrontal cortex infusion of SCH 23390 impairs the strong fear response in high-fear-reactivity rats |
| Q34152472 | Cortisol modifies extinction learning of recently acquired fear in men. |
| Q34756855 | Current status of cortisol findings in post-traumatic stress disorder |
| Q40892385 | Depressive, anxiety and posttraumatic stress disorders as long-term sequelae of intensive care treatment |
| Q35565318 | Early Psychosocial and Pharmacological Interventions After Traumatic Events |
| Q46670491 | Effect of sertraline on glucocorticoid sensitivity of mononuclear leukocytes in post-traumatic stress disorder |
| Q34141972 | Effects of acute cortisol administration on perceptual priming of trauma-related material |
| Q34137835 | Effects of early albuterol (salbutamol) administration on the development of posttraumatic stress symptoms |
| Q45767665 | Effects of hydrocortisone on posttraumatic stress disorder after septic shock: results from the CORTICUS Berlin Study Group |
| Q34554713 | Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery |
| Q45332409 | Enhanced effects of cortisol administration on episodic and working memory in aging veterans with PTSD. |
| Q48285576 | Epigenetic modification of the glucocorticoid receptor gene is linked to traumatic memory and post-traumatic stress disorder risk in genocide survivors |
| Q36557714 | Establishing an agenda for translational research on PTSD. |
| Q34465555 | Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology |
| Q53091817 | Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. |
| Q36503064 | Factors associated with posttraumatic stress symptoms in a prospective cohort of patients after abdominal sepsis: a nomogram |
| Q47674841 | Familial risk for insomnia is associated with abnormal cortisol response to stress |
| Q35575671 | Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress |
| Q64240022 | Glucocorticoid-induced enhancement of extinction-from animal models to clinical trials |
| Q36557690 | Glucocorticoid-induced inhibition of memory retrieval: implications for posttraumatic stress disorder |
| Q37013645 | Glucocorticoid-induced reduction of traumatic memories: implications for the treatment of PTSD. |
| Q93193099 | Glucocorticoids and resilience |
| Q34973766 | Glucocorticoids and the regulation of memory in health and disease |
| Q37876499 | Glucocorticoids in sepsis: dissecting facts from fiction |
| Q37120920 | Glucocorticoids protect against the delayed behavioral and cellular effects of acute stress on the amygdala |
| Q37818507 | HPA axis alterations in mental disorders: impact on memory and its relevance for therapeutic interventions |
| Q39286321 | Heterogeneity of cognitive-neurobiological determinants of resilience |
| Q30465311 | Hydrocortisone suppression of the fear-potentiated startle response and posttraumatic stress disorder |
| Q44909143 | Impact of impaired sleep on the development of PTSD symptoms in combat veterans: a prospective longitudinal cohort study |
| Q37013117 | Incidence and Risk Factors for Intensive Care Unit-related Post-traumatic Stress Disorder in Veterans and Civilians. |
| Q47971714 | Intensive Care Unit Delirium and Intensive Care Unit-Related Posttraumatic Stress Disorder |
| Q35559182 | Intensive care diaries reduce new onset post traumatic stress disorder following critical illness: a randomised, controlled trial |
| Q64285486 | Interventions after acute stress prevent its delayed effects on the amygdala |
| Q36928222 | Investigating risk factors for psychological morbidity three months after intensive care: a prospective cohort study |
| Q38816003 | Literature review of post-traumatic stress disorder in the critical care population. |
| Q92407179 | Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders |
| Q41696954 | Neurological and psychological long-term effects of sepsis |
| Q64921985 | Neurological outcome after bacterial meningitis: bridging the gap from molecules to behavior. |
| Q34228145 | New insights into secondary prevention in post-traumatic stress disorder. |
| Q26829332 | Patient-reported outcomes in post-traumatic stress disorder. Part II: focus on pharmacological treatment |
| Q59049894 | Pharmacological Prevention of Posttraumatic Stress Disorder: A Systematic Review |
| Q22337441 | Pharmacological interventions for preventing post-traumatic stress disorder (PTSD) |
| Q33734824 | Pharmacological modulation of acute trauma memories to prevent PTSD: considerations from a developmental perspective |
| Q91825048 | Pharmacological prevention and early treatment of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis |
| Q38584844 | Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis |
| Q24633256 | Pharmacological treatment of PTSD - established and new approaches |
| Q34062435 | Pharmacotherapy for posttraumatic stress disorder |
| Q24244707 | Pharmacotherapy for prevention of post-traumatic stress disorder |
| Q36777691 | Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials |
| Q35686859 | Pharmacotherapy of anxiety disorders: a critical review |
| Q30448784 | Post-exposure sleep deprivation facilitates correctly timed interactions between glucocorticoid and adrenergic systems, which attenuate traumatic stress responses |
| Q59785696 | Post-traumatic stress disorder |
| Q84478566 | Post-traumatic stress disorder |
| Q36296578 | Post-traumatic stress disorder and post-traumatic stress symptoms following critical illness in medical intensive care unit patients: assessing the magnitude of the problem |
| Q37013641 | Post-traumatic stress disorder in somatic disease: lessons from critically ill patients |
| Q36133824 | Post-traumatic stress disorder in women: epidemiological and treatment issues |
| Q45220574 | Post-traumatic stress disorder symptoms after acute lung injury: a 2-year prospective longitudinal study. |
| Q93181348 | Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges |
| Q36909270 | Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies |
| Q34453859 | Post-traumatic stress disorder: revisiting adrenergics, glucocorticoids, immune system effects and homeostasis |
| Q34359824 | Posttraumatic Stress Disorder and Acute Stress Disorder II: Considerations for Treatment and Prevention |
| Q36948162 | Posttraumatic stress disorder in general intensive care unit survivors: a systematic review |
| Q35663226 | Posttraumatic stress disorder in organ transplant recipients: a systematic review |
| Q91911396 | Posttraumatic stress disorder in survivors of acute respiratory distress syndrome (ARDS) and septic shock |
| Q35136227 | Posttraumatic stress in intensive care unit survivors - a prospective study |
| Q37112361 | Predictors of posttraumatic stress and quality of life in family members of chronically critically ill patients after intensive care |
| Q37320426 | Predictors of posttraumatic stress disorder and return to usual major activity in traumatically injured intensive care unit survivors |
| Q64899436 | Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis. |
| Q37808704 | Preventing post traumatic stress disorder: are drugs the answer? |
| Q26769597 | Prevention of Post-Traumatic Stress Disorder After Trauma: Current Evidence and Future Directions |
| Q28083758 | Prevention of Trauma and Stressor-Related Disorders: A Review |
| Q26778630 | Primary prevention of posttraumatic stress disorder: drugs and implications |
| Q44652946 | Prior exposure to a single stress session facilitates subsequent contextual fear conditioning in rats. Evidence for a role of corticosterone. |
| Q37734444 | Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome |
| Q38185606 | Prospects for the pharmacological prevention of post-traumatic stress in vulnerable individuals |
| Q47810579 | Psychiatric Symptoms in Survivors of Acute Respiratory Distress Syndrome. Effects of Age, Sex, and Immune Modulation. |
| Q33750610 | Psychosocial Response to Mass Casualty Terrorism: Guidelines for Physicians |
| Q91989431 | Reduction in the occurrence of distressing involuntary memories following propranolol or hydrocortisone in healthy women |
| Q30412306 | Relation between corticosterone and fear-related behavior in mice selectively bred for high or low alcohol preference |
| Q27004411 | Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis |
| Q36558144 | Resilience: research evidence and conceptual considerations for posttraumatic stress disorder. |
| Q36191978 | Social, psychological, and psychiatric interventions following terrorist attacks: recommendations for practice and research |
| Q54937509 | Steroids for sepsis: yes, no or maybe. |
| Q38771510 | Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor. |
| Q39018484 | Stress, glucocorticoids and memory: implications for treating fear-related disorders |
| Q40177668 | Stressing the Brain: The Immune System, Hypothalamic-Pituitary-Adrenal Axis, and Psychiatric Symptoms in Acute Respiratory Distress Syndrome Survivors. |
| Q24647348 | Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic |
| Q27016155 | Targeting memory processes with drugs to prevent or cure PTSD |
| Q33900638 | The Impact of Stress Hormones on Post-traumatic Stress Disorders Symptoms and Memory in Cardiac Surgery Patients. |
| Q36557725 | The contribution of an animal model toward uncovering biological risk factors for PTSD. |
| Q48490029 | The efficacy of initial hydrocortisone administration at preventing posttraumatic distress in adult trauma patients: a randomized trial |
| Q36844763 | The prevalence of post traumatic stress disorder in survivors of ICU treatment: a systematic review. |
| Q30397589 | The role of stress and fear in the development of mental disorders |
| Q34865036 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision |
| Q83340506 | [Corticosteroid insufficiency in the critically ill. Pathomechanisms and recommendations for diagnosis and treatment] |
| Q52841238 | [Posttraumatic stress disorder after intensive care : Prevalence, risk factors, and treatment]. |
| Q50721942 | [Prophylaxis and therapy of post-traumatic stress disorder with propranolol: evidence and ethical analysis]. |
Search more.